Related references
Note: Only part of the references are listed.Comparison of Osteoprotegerin to Traditional Atherosclerotic Risk Factors and High-Sensitivity C-Reactive Protein for Diagnosis of Atherosclerosis
Rasmus Mogelvang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Biomarkers of the Osteoprotegerin Pathway Clinical Correlates, Subclinical Disease, Incident Cardiovascular Disease, and Mortality
Wolfgang Lieb et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Osteoprotegerin, vascular calcification and atherosclerosis
Ann Van Campenhout et al.
ATHEROSCLEROSIS (2009)
Regulatory Effect of Parathyroid Hormone on sRANKL-Osteoprotegerin in Hemodialysis Patients With Renal Bone Disease
Konstantinos Doumouchtsis et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2009)
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Brendan F. Boyce et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Relation of osteoprotegerin to coronary calcium and aortic plaque (from The Dallas Heart Study)
Moeen Abedin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Bone density and markers of bone remodeling in type 1 male diabetic patients
O. Alexopoulou et al.
DIABETES & METABOLISM (2006)
Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis
S Gonnelli et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
PTH differentially regulates expression of RANKL and OPG
JC Huang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Increased serum osteoprotegerin level in older and diabetic hemodialysis patients
S Doi et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2004)
Arterial calcifications and bone histomorphometry in end-stage renal disease
GM London et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulate aortic valve calcification
JJ Kaden et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients
K Nitta et al.
HYPERTENSION RESEARCH (2004)
Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients
J Malyszko et al.
TRANSPLANTATION PROCEEDINGS (2003)
Modeling of bone formation and resorption mediated by parathyroid hormone: response to estrogen/PTH therapy
C Rattanakul et al.
BIOSYSTEMS (2003)
Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure
JJ Kazama et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Osteoprotegerin levels before and after renal transplantation
T Sato et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
LC Hofbauer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Effects of immunosuppressants on receptor activator of NF-κB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
LC Hofbauer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
LC Hofbauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
